Home
GMS Ventures & Investments reported a 38.6% stake in Outlook Therapeutics OTLK · 12,725,216 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 38.6%
- Last report
- No earlier report
- Shares held
- 12,725,216 sh
- Class
- Common Stock, par value $0.01 per share
- Event date
- 25/01/17
- Filed
- 25/01/22
38.6% stake
Outlook Therapeutics trades, last 26 weeks
What else happened in Outlook Therapeutics around then
Filed or reported within 30 days of the trade day · 24/12/18~25/02/16GMS Ventures & Investments's other 5% stake reports
- GMS Ventures & Investments
5% stakeOutlook Therapeutics
5% stakeOutlook Therapeutics
OTLK
16.4% stake
42,631,142 sh
16.4% stake
Filed 08/14
- GMS Ventures & Investments
5% stakeOutlook Therapeutics
5% stakeOutlook Therapeutics
OTLK
22.9% stake
37,580,638 sh
22.9% stake
Filed 06/01
- GMS Ventures & Investments
5% stakeOutlook Therapeutics
5% stakeOutlook Therapeutics
OTLK
50.3% stake
29,040,929 sh
50.3% stake
Filed 25/05/28
- GMS Ventures & Investments
5% stakeOutlook Therapeutics
5% stakeOutlook Therapeutics
OTLK
41.6% stake
16,183,787 sh
41.6% stake
Filed 25/03/12